- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Blood lactate analyzers, also known as blood lactate testing equipment, are instruments that measure the amount of lactate in the blood. As a diagnostic tool, a blood lactate analyzer is employed. High lactate levels can be induced by shock, anaemia, sepsis, cancer, diabetes, or carbon monoxide or paracetamol toxicity.
Unfortunately, determining the lactate threshold has usually needed venous or capillary blood samples as well as a specialised metre.
Although the Surviving Sepsis Campaign recommendations promote lactate as a measure of tissue hypoperfusion when it climbs above 1.0mmol/L,(1) intensive fluid resuscitation is only indicated for patients with a lactate level above 4.0mmol/L due to its associated with increased mortality.
The Global Blood Lactate Analyzer market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
EKF Introduces a Point-of-Care Lactate Analyzer with Hematocrit Compensation EKF Diagnostics has released a new version of its Lactate Scout+ analyzer. Lactate Scout was originally designed to give coaches and athletes a precise and easy-to-use mobile lactate test.
However, the device's added features and functionality, including hematocrit adjustment, now allow it to be utilised in new medical applications.Lactate Scout+'s hematocrit (Hct) adjustment guarantees reliable lactate measurements even at high (>50%) or low (35%) Hct levels.
The Hct range of the new analyzer is 20-70%, which means that patients with either very low Hct levels (e.g., after blood loss) or very high levels (e.g., professional athletes and neonates) can be reliably analysed.
This makes Lactate Scout+ suitable for a wide range of medicinal applications. These include well-established aerobic training, weight loss, and fitness uses, as well as emerging applications in obstetrics.
EKF has been participating in research initiatives studying lactate applications in obstetric medicine as a world leader in lactate. Cord blood lactate (CBL) analysis, for example, can provide a picture of acid-base balance at delivery and is especially suggested after high-risk deliveries.
In complex births where there is a risk of insufficient foetal oxygen supply, foetal scalp lactate (FSL) can be utilised to confirm aberrant cardiotocography readings and the need for prompt intervention.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introdauction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in theIndustry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.